HHealthcare Read More Pfizer’s monthly obesity injection drove shows promise in trialFebruary 3, 2026 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 30, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
MMedication Read More Medicare drug price negotiations: New targets include Trulicity, RexultiJanuary 28, 2026 WASHINGTON — The Trump administration on Tuesday released the next 15 drugs subject to Medicare price negotiation, including…
HHealthcare Read More Roche moves obesity drug to pivotal trials after mid-stage successJanuary 27, 2026 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
MMedication Read More Japan to designate eight ingredients for list of drugs with abuse riskJanuary 25, 2026 The health ministry will designate eight drug ingredients as having abuse potential under the law in response to…
HHealthcare Read More Next steps for Eli Lilly, Novo Nordisk, PfizerJanuary 23, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George…
MMedication Read More Number of new U.S. drug shortages hits lowest level in 20 yearsJanuary 23, 2026 The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly…
HHealthcare Read More J&J wants to be the leader in the cancer fight. Its strategy is starting to pay off as oncology sales top $25 billion in 2025.January 21, 2026 Last Updated: Jan. 21, 2026 at 10:14 a.m. ETFirst Published: Jan. 21, 2026 at 7:26 a.m. ET Johnson & Johnson…
HHealthcare Read More Another alliance of health care and AI signals why pharma stocks could be backJanuary 20, 2026 Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
MMedication Read More Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead – MarketWatchJanuary 17, 2026 Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead MarketWatchThe Truth…
HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…